|
Diabetes
|
|
|
The Food and Drug Administration on Jan. 30 approved a type 2 diabetes therapy that combines linagliptin and metformin in a single tablet taken twice daily.* The approval was announced by Eli Lilly and Boehringer Ingelheim. The companies jointly developed the tablet, to be marketed as Jentadueto.... »
Discharge rates for nontraumatic lower extremity amputation among diabetic individuals aged 40 years and older declined 65% from 1996 to 2008, according to a study by the Centers for Disease and Prevention, announced by the agency on Jan. 24 and also published in the February issue of Diabetes... »
Other contenders in a novel class of glucose-lowering agents are waiting in the wings, despite a negative reception by the Food and Drug Administration on dapagliflozin – the first in that class of agents – presumably because of concerns noted by an FDA advisory panel about potential increases in... »
Interested in being notified of new Diabetes news?
Click here to view our Diabetes RSS Feed.
| Feb 5 - 12 Departs Ft. Lauderdale, FL | Preventive Medicine |
| Feb 6 - 11 Dallas, TX | Society for Maternal-Fetal Medicine (SMFM): Annual Meeting (The Pregnancy Meeting) |
| Feb 6 - 10 Sarasota, FL | Rheumatology: Improving Primary Care Outcomes Through Diagnosis and Treatment |
| Feb 7 - 11 San Francisco, CA | American Academy of Orthopaedic Surgeons (AAOS): Annual Meeting |
| Feb 8 - 12 Naples, FL | Dermatology Foundation (DF): Clinical Symposia |
| Feb 8 - 11 Barcelona, | International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) |
| Feb 8 - 10 San Diego, CA | American Academy of Emergency Medicine (AAEM): Annual Scientific Assembly |
| Feb 9 - 11 New York, NY | Integrative Healthcare Symposium |
| Feb 9 - 11 New Orleans, LA | American Federation for Medical Research (AFMR): Southern Regional Meeting |
| Feb 12 - 15 Freiburg, | German Society for Thoracic and Cardiovascular Surgery: 41st Annual Meeting |